159 related articles for article (PubMed ID: 34955446)
1. Frailty and treatment outcome in advanced gastro-oesophageal cancer: An exploratory analysis of the GO2 trial.
Pearce J; Swinson D; Cairns D; Nair S; Baxter M; Petty R; Seymour M; Hall P; Velikova G;
J Geriatr Oncol; 2022 Apr; 13(3):287-293. PubMed ID: 34955446
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Quality of Life and Cancer Control Among Older and Frail Patients With Advanced Gastroesophageal Cancer: The GO2 Phase 3 Randomized Clinical Trial.
Hall PS; Swinson D; Cairns DA; Waters JS; Petty R; Allmark C; Ruddock S; Falk S; Wadsley J; Roy R; Tillett T; Nicoll J; Cummins S; Mano J; Grumett S; Stokes Z; Kamposioras KV; Chatterjee A; Garcia A; Waddell T; Guptal K; Maisey N; Khan M; Dent J; Lord S; Crossley A; Katona E; Marshall H; Grabsch HI; Velikova G; Ow PL; Handforth C; Howard H; Seymour MT;
JAMA Oncol; 2021 Jun; 7(6):869-877. PubMed ID: 33983395
[TBL] [Abstract][Full Text] [Related]
3. Influence of interdisciplinary frailty screening on perioperative complication rates in elderly ovarian cancer patients: results of a retrospective observational study.
Anic K; Varchola J; Schmidt MW; Schwab R; Linz VC; Schmidt M; Hardt R; Hartmann EK; Ruckes C; Hasenburg A; Battista MJ
Arch Gynecol Obstet; 2023 Jun; 307(6):1929-1940. PubMed ID: 36434440
[TBL] [Abstract][Full Text] [Related]
4. External validation and diagnostic value of the Elderly Functional Index version 2.0 for assessing functional status and frailty in older Danish patients with gastrointestinal cancer receiving chemotherapy: A prospective, clinical study.
Jespersen E; Soo WK; Minet LR; Eshoj HR; King MT; Pfeiffer P; Möller S
J Geriatr Oncol; 2024 Jan; 15(1):101675. PubMed ID: 38070322
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of baseline functional status measures and geriatric screening in vulnerable older patients with metastatic colorectal cancer receiving palliative chemotherapy - The randomized NORDIC9-study.
Liposits G; Ryg J; Skuladottir H; Winther SB; Möller S; Hofsli E; Shah CH; Poulsen LØ; Berglund Å; Qvortrup C; Osterlund P; Glimelius B; Sorbye H; Pfeiffer P
J Geriatr Oncol; 2023 Jan; 14(1):101408. PubMed ID: 36494261
[TBL] [Abstract][Full Text] [Related]
6. The role of frailty in modifying physical function and quality of life over time in older men with metastatic castration-resistant prostate cancer.
Kim VS; Yang H; Timilshina N; Breunis H; Emmenegger U; Gregg R; Hansen AR; Tomlinson G; Alibhai SMH
J Geriatr Oncol; 2023 Mar; 14(2):101417. PubMed ID: 36682218
[TBL] [Abstract][Full Text] [Related]
7. Frailty in Non-geriatric Patients With Head and Neck cancer.
Bakas AT; Polinder-Bos HA; Streng F; Mattace-Raso FUS; Ziere G; de Jong RJB; Sewnaik A
Otolaryngol Head Neck Surg; 2023 Nov; 169(5):1215-1224. PubMed ID: 37264978
[TBL] [Abstract][Full Text] [Related]
8. A randomized clinical study on the impact of Comprehensive Geriatric Assessment (CGA) based interventions on the quality of life of elderly, frail, onco-hematologic patients candidate to anticancer therapy: protocol of the ONCO-Aging study.
Mahmoud AM; Biello F; Maggiora PM; Bruna R; Burrafato G; Cappelli M; Varughese F; Martini V; Platini F; Deambrogi C; Patriarca A; Nicolosi M; Vachanaram AR; Pisani C; Ferrara E; Catania E; Azzolina D; Barone-Adesi F; Krengli M; Gaidano G; Gennari A
BMC Geriatr; 2021 May; 21(1):320. PubMed ID: 34011271
[TBL] [Abstract][Full Text] [Related]
9. Prospective comparison of the value of CARG, G8, and VES-13 toxicity tools in predicting chemotherapy-related toxicity in older Turkish patients with cancer.
Cavdar E; Iriagac Y; Karaboyun K; Avci O; Seber ES
J Geriatr Oncol; 2022 Jul; 13(6):821-827. PubMed ID: 35361561
[TBL] [Abstract][Full Text] [Related]
10. Frailty assessment tools predict perioperative outcome in elderly patients with endometrial cancer better than age or BMI alone: a retrospective observational cohort study.
Anic K; Flohr F; Schmidt MW; Krajnak S; Schwab R; Schmidt M; Westphalen C; Eichelsbacher C; Ruckes C; Brenner W; Hasenburg A; Battista MJ
J Cancer Res Clin Oncol; 2023 Apr; 149(4):1551-1560. PubMed ID: 35579719
[TBL] [Abstract][Full Text] [Related]
11. The effect of geriatric intervention in frail elderly patients receiving chemotherapy for colorectal cancer: a randomized trial (GERICO).
Lund CM; Vistisen KK; Dehlendorff C; Rønholt F; Johansen JS; Nielsen DL
BMC Cancer; 2017 Jun; 17(1):448. PubMed ID: 28659138
[TBL] [Abstract][Full Text] [Related]
12. Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial.
Kang YK; Chen LT; Ryu MH; Oh DY; Oh SC; Chung HC; Lee KW; Omori T; Shitara K; Sakuramoto S; Chung IJ; Yamaguchi K; Kato K; Sym SJ; Kadowaki S; Tsuji K; Chen JS; Bai LY; Oh SY; Choda Y; Yasui H; Takeuchi K; Hirashima Y; Hagihara S; Boku N
Lancet Oncol; 2022 Feb; 23(2):234-247. PubMed ID: 35030335
[TBL] [Abstract][Full Text] [Related]
13. Preoperative frailty assessment with the Robinson Frailty Score, Edmonton Frail Scale, and G8 and adverse postoperative outcomes in older surgical patients with cancer.
Nishijima TF; Esaki T; Morita M; Toh Y
Eur J Surg Oncol; 2021 Apr; 47(4):896-901. PubMed ID: 33036830
[TBL] [Abstract][Full Text] [Related]
14. Screening for frailty among older patients with cancer that qualify for abdominal surgery.
Kenig J; Zychiewicz B; Olszewska U; Richter P
J Geriatr Oncol; 2015 Jan; 6(1):52-9. PubMed ID: 25277874
[TBL] [Abstract][Full Text] [Related]
15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
16. Comparison of two frailty screening tools in older patients with colorectal cancer.
Zhao H; Lu X; Zheng S; Wei D; Zhao L; Wang Y; de Bock GH; Lu W
BMC Geriatr; 2023 May; 23(1):295. PubMed ID: 37189055
[TBL] [Abstract][Full Text] [Related]
17. The preoperative G8 geriatric screening tool independently predicts survival in older patients with endometrial cancer: results of a retrospective single-institution cohort study.
Anic K; Altehoefer C; Krajnak S; Schmidt MW; Schwab R; Linz VC; Schmidt M; Westphalen C; Hartmann EK; Hasenburg A; Battista MJ
J Cancer Res Clin Oncol; 2023 Feb; 149(2):851-863. PubMed ID: 35212815
[TBL] [Abstract][Full Text] [Related]
18. Pilot study of the implementation of G8 screening tool, Cognitive screening assessment and Chemotherapy Toxicity assessment in older adults with cancer in a Tertiary University Hospital in Ireland.
AlSendi M; Flynn CR; Khan MR; Selvadurai P; Crown J; McDermott RS; Walshe JM; Fennelly DW; Hanrahan EO; Doherty M; Higgins MJ
Ir J Med Sci; 2024 Feb; 193(1):45-50. PubMed ID: 37450258
[TBL] [Abstract][Full Text] [Related]
19. The G8 frailty screening tool and the decision-making process in older breast cancer patients.
Scheepers ERM; van der Molen LF; van den Bos F; Burgmans JP; van Huis-Tanja LH; Hamaker ME
Eur J Cancer Care (Engl); 2021 Jan; 30(1):e13357. PubMed ID: 33159382
[TBL] [Abstract][Full Text] [Related]
20. Ramucirumab plus pembrolizumab in patients with previously treated advanced non-small-cell lung cancer, gastro-oesophageal cancer, or urothelial carcinomas (JVDF): a multicohort, non-randomised, open-label, phase 1a/b trial.
Herbst RS; Arkenau HT; Santana-Davila R; Calvo E; Paz-Ares L; Cassier PA; Bendell J; Penel N; Krebs MG; Martin-Liberal J; Isambert N; Soriano A; Wermke M; Cultrera J; Gao L; Widau RC; Mi G; Jin J; Ferry D; Fuchs CS; Petrylak DP; Chau I
Lancet Oncol; 2019 Aug; 20(8):1109-1123. PubMed ID: 31301962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
